Literature DB >> 11567801

Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy.

S Hirota1, K Tsujino, M Endo, Y Kotani, M Satouchi, T Kado, Y Hishikawa, K Obayashi, Y Takada, M Kono, M Abe.   

Abstract

PURPOSE: To establish dosimetric predictors of radiation esophagitis (RE) in patients treated with a combination of carboplatin, paclitaxel, and radiotherapy. METHODS AND MATERIALS: Three-dimensional radiotherapy plans of 26 patients with non-small-cell lung cancer who received 50-60 Gy of radiotherapy concurrently with weekly administration of carboplatin (AUC 2) and paclitaxel (40-45 mg/m(2)) were reviewed in conjunction with RE. The factors analyzed included the following: percentages of organ volumes receiving >40 Gy (V40), >45 Gy (V45), >50 Gy (V50), and >55 Gy (V55); the length of esophagus (total circumference) treated with >40 Gy (LETT40), >45 Gy (LETT45), >50 Gy (LETT50), and >55 Gy (LETT55); the maximum dose in the esophagus (Dmax); and the mean dose in the esophagus (Dmean). Data were obtained on the basis of superposition algorithm.
RESULTS: All factors except Dmax showed statistical correlation with RE. Good correlations were shown between RE and LETT45 (rho = 0.714) and V45 (rho = 0.686).
CONCLUSIONS: LETT45 and V45 appear to be useful dosimetric predictors of RE. It is also suggested that Dmax does not predict RE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11567801     DOI: 10.1016/s0360-3016(01)01648-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

Review 1.  Lung cancer 5: state of the art radiotherapy for lung cancer.

Authors:  A Price
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  Spanish radiobiological pattern of care in lung cancer: a GOECP/SEOR study.

Authors:  J A González; M Chust; R Delgado; A Gómez; N Rodríguez; M J Ruiz; F Casas
Journal:  Clin Transl Oncol       Date:  2010-04       Impact factor: 3.405

3.  Dosimetric factors associated with weight loss during (chemo)radiotherapy treatment for lung cancer.

Authors:  N Kiss; M Krishnasamy; S Everitt; K Gough; M Duffy; E Isenring
Journal:  Eur J Clin Nutr       Date:  2014-08-13       Impact factor: 4.016

4.  Modeling the risk of radiation-induced acute esophagitis for combined Washington University and RTOG trial 93-11 lung cancer patients.

Authors:  Ellen X Huang; Jeffrey D Bradley; Issam El Naqa; Andrew J Hope; Patricia E Lindsay; Walter R Bosch; John W Matthews; William T Sause; Mary V Graham; Joseph O Deasy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-14       Impact factor: 7.038

5.  Esophageal tolerance to high-dose stereotactic radiosurgery.

Authors:  Bo Mi Lee; Sei Kyung Chang; Seung Young Ko; Seung Hoon Yoo; Hyun Soo Shin
Journal:  Radiat Oncol J       Date:  2013-12-31

6.  Independent test of a model to predict severe acute esophagitis.

Authors:  Ellen X Huang; Clifford G Robinson; Alerson Molotievschi; Jeffrey D Bradley; Joseph O Deasy; Jung Hun Oh
Journal:  Adv Radiat Oncol       Date:  2016-11-16

7.  Analysis of esophageal-sparing treatment plans for patients with high-grade esophagitis.

Authors:  Joshua Niedzielski; Jaques B Bluett; Ryan T Williamson; Zhongxing Liao; Daniel R Gomez; Laurence E Court
Journal:  J Appl Clin Med Phys       Date:  2013-07-08       Impact factor: 2.102

8.  Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy.

Authors:  Farkhad Manapov; Susanna Sepe; Maximilian Niyazi; Claus Belka; Godehard Friedel; Wilfried Budach
Journal:  Radiat Oncol       Date:  2013-05-17       Impact factor: 3.481

Review 9.  Acute and Late Toxicities of Concurrent Chemoradiotherapy for Locally-Advanced Non-Small Cell Lung Cancer.

Authors:  Vivek Verma; Charles B Simone; Maria Werner-Wasik
Journal:  Cancers (Basel)       Date:  2017-09-08       Impact factor: 6.639

10.  Clinical, dosimetric, and position factors for radiation-induced acute esophagitis in intensity-modulated (chemo)radiotherapy for locally advanced non-small-cell lung cancer.

Authors:  Jin Huang; Tianyu He; Ronghui Yang; Tianlong Ji; Guang Li
Journal:  Onco Targets Ther       Date:  2018-09-21       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.